ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway.
- DOI
- 10.3389/fphar.2019.01596
- Published
- 2019
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 12/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- cautionRetraction Watch correction: 1 correction notice matched this DOI.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2019.01596,
title = {ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway.},
author = {Shen YL and Jiang YP and Li XQ and Wang SJ and Ma MH and Zhang CY and Zhu JY and Rahman K and Zhang LJ and Luan X and Zhang H},
year = {2019},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2019.01596},
url = {https://doi.org/10.3389/fphar.2019.01596}
}RIS
TY - JOUR TI - ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway. AU - Shen YL AU - Jiang YP AU - Li XQ AU - Wang SJ AU - Ma MH AU - Zhang CY AU - Zhu JY AU - Rahman K AU - Zhang LJ AU - Luan X AU - Zhang H PY - 2019 JO - Frontiers in pharmacology DO - 10.3389/fphar.2019.01596 UR - https://doi.org/10.3389/fphar.2019.01596 ER -
APA
YL, S., YP, J., XQ, L., SJ, W., MH, M., CY, Z., JY, Z., K, R., LJ, Z., X, L., & H, Z. (2019). ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2019.01596